Long COVID neuropsychological follow-up: Is cognitive rehabilitation relevant?

NeuroRehabilitation. 2023;53(4):517-534. doi: 10.3233/NRE-230212.

Abstract

Background: Duration of neuropsychological disorders caused by long COVID, and the variables that impact outcomes, are still largely unknown.

Objective: To describe the cognitive profile of patients with long COVID post-participation in a neuropsychological rehabilitation program and subsequent reassessment and identify the factors that influence recovery.

Methods: 208 patients (mean age of 48.8 y.o.), mostly female, were reevaluated 25 months after their first COVID infection and 17 months after their initial evaluation. Patients underwent subjective assessment, Barrow Neurological Institute Screen for Higher Cerebral Functions (BNIS), Phonemic Verbal Fluency and Clock Drawing Tests (NEUPSILIN) for executive functions, Hospital Anxiety and Depression Scale (HADS) and WHOQol-Bref.

Results: We noted a discrete improvement of neuropsychological symptoms 25 months after the acute stage of COVID-19; nonetheless, performance was not within the normative parameters of standardized neuropsychological testing. These results negatively impact QoL and corroborate patients' subjective assessments of cognitive issues experienced in daily life. Improvement was seen in those who participated in psychoeducational neuropsychological rehabilitation, had higher levels of education, and lower depression scores on the HADS.

Conclusion: Our data reveal the persistence of long-term cognitive and neuropsychiatric disorders in patients with long COVID. Neuropsychological rehabilitation is shown to be important, whether in-person or online.

Keywords: COVID-19; cognitive dysfunction; cognitive training; neuropsychological tests; post-acute COVID-19 syndrome.

MeSH terms

  • COVID-19* / complications
  • Cognitive Dysfunction* / etiology
  • Cognitive Dysfunction* / psychology
  • Cognitive Training
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Post-Acute COVID-19 Syndrome
  • Quality of Life